CXCR2 and neoplasm: For example, in pancreatic adenocarcinoma, NF-κB-driven expression of CXCL5 fosters tumor progression via recruitment of CXCR2+ myeloid-derived suppressor cells (MDSC) and tumor-associated neutrophils [43,44].